These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8106685)

  • 1. Atracurium and laudanosine pharmacokinetics in acute renal failure.
    Hunter JM
    Intensive Care Med; 1993; 19 Suppl 2():S91-3. PubMed ID: 8106685
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of atracurium and laudanosine in the elderly.
    Kent AP; Parker CJ; Hunter JM
    Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma in three intensive care patients.
    Gwinnutt CL; Eddleston JM; Edwards D; Pollard BJ
    Br J Anaesth; 1990 Dec; 65(6):829-32. PubMed ID: 2265055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic modelling of a parent drug and its metabolite. Atracurium and laudanosine.
    Nigrovic V; Banoub M
    Clin Pharmacokinet; 1992 May; 22(5):396-408. PubMed ID: 1505145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of infusions of atracurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU.
    Parker CJ; Jones JE; Hunter JM
    Br J Anaesth; 1988 Nov; 61(5):531-40. PubMed ID: 3207525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation.
    Bion JF; Bowden MI; Chow B; Honisberger L; Weatherley BC
    Intensive Care Med; 1993; 19 Suppl 2():S94-8. PubMed ID: 8106686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery.
    Eddleston JM; Harper NJ; Pollard BJ; Edwards D; Gwinnutt CL
    Br J Anaesth; 1989 Nov; 63(5):525-30. PubMed ID: 2605068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of atracurium and laudanosine in the urine and by continuous venovenous haemofiltration.
    Shearer ES; O'Sullivan EP; Hunter JM
    Br J Anaesth; 1991 Nov; 67(5):569-73. PubMed ID: 1751271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
    Parker CJ; Hunter JM
    Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium infusions in patients with renal failure on an ITU.
    Griffiths RB; Hunter JM; Jones RS
    Anaesthesia; 1986 Apr; 41(4):375-81. PubMed ID: 3518532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid concentrations of laudanosine after administration of atracurium.
    Fahey MR; Canfell PC; Taboada T; Hosobuchi Y; Miller RD
    Br J Anaesth; 1990 Jan; 64(1):105-6. PubMed ID: 2302366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and atracurium and laudanosine concentrations during a fixed continuous infusion of atracurium in mechanically ventilated patients with acute respiratory distress syndrome.
    Lefrant JY; Farenc C; De la Coussaye JE; Muller L; Ripart J; Cuvillon P; Saissi G; Eledjam JJ
    Anaesth Intensive Care; 2002 Aug; 30(4):422-7. PubMed ID: 12180578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.
    Ward S; Boheimer N; Weatherley BC; Simmonds RJ; Dopson TA
    Br J Anaesth; 1987 Jun; 59(6):697-706. PubMed ID: 3606914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laudanosine and atracurium concentrations in a patient receiving long-term atracurium infusion.
    Grigore AM; Brusco L; Kuroda M; Koorn R
    Crit Care Med; 1998 Jan; 26(1):180-3. PubMed ID: 9428564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA; Schmith VD; Belmont MR; Abalos A; Kisor DF; Savarese JJ
    Anesthesiology; 1996 Feb; 84(2):300-8. PubMed ID: 8602660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of laudanosine, an atracurium metabolite, following a fatal drug-related shooting.
    Logan BK; Case GA
    J Anal Toxicol; 1993; 17(2):117-9. PubMed ID: 8492564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics.
    Farenc C; Audran M; Lefrant JY; Mazerm I; Bressolle F
    J Chromatogr B Biomed Sci Appl; 1999 Mar; 724(1):117-26. PubMed ID: 10202964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function.
    Vandenbrom RH; Wierda JM; Agoston S
    Clin Pharmacokinet; 1990 Sep; 19(3):230-40. PubMed ID: 2394062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anesthesiologist suicide with atracurium.
    Martínez MA; Ballesteros S; Almarza E
    J Anal Toxicol; 2006 Mar; 30(2):120-4. PubMed ID: 16620544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.